Osler Diagnostics company

Osler is developing a handheld diagnostic device capable of testing for a vast range of biomarkers, from just a pinprick of blood, in less than 10 minutes, and at the cost of a few dollars. This represents a ground-breaking development of a broad-purpose diagnostic device available for Point-of-Care settings; as such, it will enable testing to be faster, cheaper, easier, and more accessible. The technology is based on years of world-class academic research from the University of Oxford and has been successfully proven in a research lab context.
Technology: biomarkers
Industry: Personalized Medicine
Headquarters: Oxford, Oxfordshire, United Kingdom
Founded Date: 2016
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 1
Total Funding: £35.5M
Estimated Revenue: Less than $1M
Last Funding Type: Series A

Visit Website
Register and Claim Ownership